MEDKASYBA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 28,313 | 83,990 | 0 | 20,228 | 289,997 | 288,503 | 111,047 | 119,961 |
| Profit before tax | 6,044 | 41,040 | -29,391 | -33,780 | 260,800 | 275,747 | 83,257 | 88,076 |
| Net profit | 5,736 | 38,963 | -29,391 | -33,780 | 252,492 | 217,615 | 70,746 | 73,985 |
| Equity | -67,056 | -28,093 | -57,484 | -91,264 | 161,228 | 378,843 | 449,589 | 523,574 |
| Liabilities | 479,477 | 444,356 | 542,942 | 570,371 | 333,574 | 94,680 | 87,996 | 34,429 |
| Non-current assets | 385,270 | 385,121 | 470,688 | 470,510 | 470,333 | 470,155 | 470,096 | 470,096 |
| Current assets | 27,151 | 31,142 | 14,770 | 8,597 | 24,469 | 3,368 | 67,489 | 87,907 |
| Total assets | 412,421 | 416,263 | 485,458 | 479,107 | 494,802 | 473,523 | 537,585 | 558,003 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 88,514 | 61,154 | 62,957 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | +196.6% | - | - | +1333.6% | -0.5% | -61.5% | +8.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 1.4% | 9.4% | -6.1% | -7.1% | 51.0% | 46.0% | 13.2% | 13.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | 156.6% | 57.4% | 15.7% | 14.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 20.3% | 46.4% | - | -167.0% | 87.1% | 75.4% | 63.7% | 61.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 21.3% | 48.9% | - | -167.0% | 89.9% | 95.6% | 75.0% | 73.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | 2.1 | 0.2 | 0.2 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 14,157 | 34,754 | - | 6,743 | 99,426 | 96,168 | 37,016 | 39,987 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
MEDKASYBA - Social security debts
The company had no debts to Sodra
MEDKASYBA - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
MEDKASYBA, UAB, code 302338231, is a Private Limited Liability Company engaged in the operation of gravel and sand pits and mining of clay and kaolin. In 2025, the company generated revenue of €120.0K and net profit of €74.0K, corresponding to a profit margin of 61.7%. Revenue increased by 8.0% year on year, although it remained 58.4% below the 2023 level. The three-year trajectory shows a sharp decline from €288.5K revenue and €217.6K net profit in 2023 to €111.0K revenue and €70.7K net profit in 2024, followed by a modest recovery in 2025. The balance sheet remained strong in 2025, with total assets of €558.0K, equity of €523.6K and liabilities of €34.4K. The equity ratio was 93.8% and debt-to-equity 0.07, indicating very low leverage. Return on equity was 14.1% and return on assets 13.3%. Asset turnover was 0.21x. With revenue per employee of €40.0K and profit per employee of €24.7K, the business shows solid profitability relative to its scale.